4.6 Article

Crystal Structure of the Stress-Inducible Human Heat Shock Protein 70 Substrate-Binding Domain in Complex with Peptide Substrate

期刊

PLOS ONE
卷 9, 期 7, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0103518

关键词

-

资金

  1. US Public Health Service National Institutes of Health [R01CA139319, PO1CA114046]

向作者/读者索取更多资源

The HSP70 family of molecular chaperones function to maintain protein quality control and homeostasis. The major stress-induced form, HSP70 (also called HSP72 or HSPA1A) is considered an important anti-cancer drug target because it is constitutively overexpressed in a number of human cancers and promotes cancer cell survival. All HSP70 family members contain two functional domains: an N-terminal nucleotide binding domain (NBD) and a C-terminal protein substrate-binding domain (SBD); the latter is subdivided into SBD alpha and SBD beta subdomains. The NBD and SBD structures of the bacterial ortholog, DnaK, have been characterized, but only the isolated NBD and SBD alpha segments of eukaryotic HSP70 proteins have been determined. Here we report the crystal structure of the substrate-bound human HSP70-SBD to 2 angstrom resolution. The overall fold of this SBD is similar to the corresponding domain in the substrate-bound DnaK structures, confirming a similar overall architecture of the orthologous bacterial and human HSP70 proteins. However, conformational differences are observed in the peptide-HSP70-SBD complex, particularly in the loop L-alpha,L-beta that bridges SBD alpha to SBD beta, and the loop L-L,L-1 that connects the SBD and NBD. The interaction between the SBD alpha and SBD beta subdomains and the mode of substrate recognition is also different between DnaK and HSP70. This suggests that differences may exist in how different HSP70 proteins recognize their respective substrates. The high-resolution structure of the substrate-bound-HSP70-SBD complex provides a molecular platform for the rational design of small molecule compounds that preferentially target this C-terminal domain, in order to modulate human HSP70 function.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Subtelomeric p53 binding prevents accumulation of DNA damage at human telomeres

Stephen Tutton, Greggory A. Azzam, Nicholas Stong, Olga Vladimirova, Andreas Wiedmer, Jessica A. Monteith, Kate Beishline, Zhuo Wang, Zhong Deng, Harold Riethman, Steven B. McMahon, Maureen Murphy, Paul M. Lieberman

EMBO JOURNAL (2016)

Article Chemistry, Medicinal

PUMA-dependent apoptosis in NSCLC cancer cells by a dimeric β-carboline

Jaruwan Chatwichien, Subhasree Basu, Anna Budina-Kolomets, Maureen E. Murphy, Jeffrey D. Winkler

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)

Article Oncology

HSP70 Inhibition Limits FAK-Dependent Invasion and Enhances the Response to Melanoma Treatment with BRAF Inhibitors

Anna Budina-Kolomets, Marie R. Webster, Julia I-Ju Leu, Matthew Jennis, Clemens Krepler, Anastasia Guerrini, Andrew V. Kossenkov, Wei Xu, Giorgos Karakousis, Lynn Schuchter, Ravi K. Amaravadi, Hong Wu, Xiangfan Yin, Qin Liu, Yiling Lu, Gordon B. Mills, Xiaowei Xu, Donna L. George, Ashani T. Weeraratna, Maureen E. Murphy

CANCER RESEARCH (2016)

Editorial Material Cell Biology

p53 family members regulate cancer stem cells

Subhasree Basu, Maureen E. Murphy

CELL CYCLE (2016)

Article Oncology

A Unified Approach to Targeting the Lysosome's Degradative and Growth Signaling Roles

Vito W. Rebecca, Michael C. Nicastri, Noel McLaughlin, Colin Fennelly, Quentin McAfee, Amruta Ronghe, Michel Nofal, Chun-Yan Lim, Eric Witze, Cynthia I. Chude, Gao Zhang, Gretchen M. Alicea, Shengfu Piao, Sengottuvelan Murugan, Rani Ojha, Samuel M. Levi, Zhi Wei, Julie S. Barber-Rotenberg, Maureen E. Murphy, Gordon B. Mills, Yiling Lu, Joshua Rabinowitz, Ronen Marmorstein, Qin Liu, Shujing Liu, Xiaowei Xu, Meenhard Herlyn, Roberto Zoncu, Donita C. Brady, David W. Speicher, Jeffrey D. Winkler, Ravi K. Amaravadi

CANCER DISCOVERY (2017)

Article Oncology

Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function

Julia I-Ju Leu, Thibaut Barnoud, Gao Zhang, Tian Tian, Zhi Wei, Meenhard Herlyn, Maureen E. Murphy, Donna L. George

ONCOTARGET (2017)

Article Oncology

The transcription-independent mitochondrial cell death pathway is defective in non-transformed cells containing the Pro47Ser variant of p53

Anna Budina-Kolomets, Thibaut Barnoud, Maureen E. Murphy

CANCER BIOLOGY & THERAPY (2018)

Article Biology

p53 orchestrates DNA replication restart homeostasis by suppressing mutagenic RAD52 and POL theta pathways

Sunetra Roy, Karl-Heinz Tomaszowski, Jessica W. Luzwick, Soyoung Park, Jun Li, Maureen Murphy, Katharina Schlacher

Article Multidisciplinary Sciences

P53 represses pyrimidine catabolic gene dihydropyrimidine dehydrogenase (DPYD) expression in response to thymidylate synthase (TS) targeting

Prashanth Gokare, Niklas K. Finnberg, Phillip H. Abbosh, Jenny Dai, Maureen E. Murphy, Wafik S. El-Deiry

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

Functional interplay among thiol-based redox signaling, metabolism, and ferroptosis unveiled by a genetic variant of TP53

Julia I-Ju Leu, Maureen E. Murphy, Donna L. George

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Review Biochemistry & Molecular Biology

Shifting the paradigms for tumor suppression: lessons from the p53 field

Thibaut Barnoud, Alexandra Indeglia, Maureen E. Murphy

Summary: The TP53 gene remains the most frequently mutated gene in cancer, driving intense research efforts to understand its role in tumor suppression. The journey towards understanding p53 function has been complex and challenging, leading to paradigm shifts and emerging challenges for future research. This review provides a valuable historical reference for those interested in p53 and highlights the importance of flexibility in the face of established paradigms.

ONCOGENE (2021)

Article Biochemistry & Molecular Biology

PLTP is a p53 target gene with roles in cancer growth suppression and ferroptosis

Keerthana Gnanapradeepan, Alexandra Indeglia, David C. Stieg, Nicole Clarke, Chunlei Shao, James F. Dougherty, Nivitha Murali, Maureen E. Murphy

Summary: The tumor suppressor protein p53 plays a crucial role in suppressing cancer by regulating processes such as cell death and growth inhibition. This study identifies PLTP as a p53 target gene that is highly sensitive to p53 transcriptional function and is involved in growth suppression and ferroptosis.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Editorial Material Oncology

p53 Oligomerization Domain Mutants: A New Class of Mutants That Retain License to Kill

David Stieg, Kaitlyn Casey, Maureen E. Murphy

Summary: In this issue of Cancer Discovery, the Prives and Lozano groups present companion articles discussing the functional analysis of a frequently occurring mutant of p53, A347D, in Li-Fraumeni disease and sporadic cancer. The authors demonstrate that this mutant has a complete loss of canonical p53 transcriptional function, but retains some tumor suppressor properties, manifested as neomorphic activities in transcription and control of mitochondrial metabolism.

CANCER DISCOVERY (2023)

Article Oncology

P53 regulates cellular redox state, ferroptosis and metabolism

Julia I-Ju Leu, Maureen E. Murphy, Donna L. George

Summary: The tumor protein P53 has intricate and sometimes conflicting roles in regulating metabolism and ferroptosis sensitivity. Its actions influence the redox state, affecting redox-sensitive proteins and modifying metabolic processes and response to ferroptosis.

MOLECULAR & CELLULAR ONCOLOGY (2021)

Article Oncology

The codon 72 polymorphism of p53 influences cell fate following nutrient deprivation

Che-Pei Kung, Qin Liu, Maureen E. Murphy

CANCER BIOLOGY & THERAPY (2017)

暂无数据